Earnings Call · Q4 FY2025·2026-03-25

Q4 25EPS -100.00%*·Rev n/aQ3 25EPS 0.00%·Rev n/aQ2 25EPS +28.57%·Rev n/aQ1 25EPS +71.43%·Rev n/a⚠ consensus missing

Cytosorbents Corp CTSO

Peter Mariani — Chief Financial Officer

Phillip Chan — Chief Executive Officer

−10.6%1d on move date−8.8% vs SPY3d−16.6%5d−18.5%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CTSO calls or request research access.

More CTSO calls Browse calls Request research access